BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34043864)

  • 1. Movement of prion-like α-synuclein along the gut-brain axis in Parkinson's disease: A potential target of curcumin treatment.
    Chetty D; Abrahams S; van Coller R; Carr J; Kenyon C; Bardien S
    Eur J Neurosci; 2021 Jul; 54(2):4695-4711. PubMed ID: 34043864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like Mechanisms.
    Chen M; Mor DE
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease from the gut.
    Liddle RA
    Brain Res; 2018 Aug; 1693(Pt B):201-206. PubMed ID: 29360467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neural Gut-Brain Axis of Pathological Protein Aggregation in Parkinson's Disease and Its Counterpart in Peroral Prion Infections.
    Beekes M
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion-like propagation of α-synuclein in the gut-brain axis.
    Chen Y; Shao Q; Yuan YH; Chen NH
    Brain Res Bull; 2018 Jun; 140():341-346. PubMed ID: 29894766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prion Properties of Alpha-Synuclein].
    Schwarzman AL; Senkevich KA; Emelyanov AK; Pchelina SN
    Mol Biol (Mosk); 2019; 53(3):380-387. PubMed ID: 31184602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?
    Lema Tomé CM; Tyson T; Rey NL; Grathwohl S; Britschgi M; Brundin P
    Mol Neurobiol; 2013 Apr; 47(2):561-74. PubMed ID: 22544647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prion hypothesis of Parkinson's disease.
    Chu Y; Kordower JH
    Curr Neurol Neurosci Rep; 2015 May; 15(5):28. PubMed ID: 25868519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
    Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
    Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concept of alpha-synuclein as a prion-like protein: ten years after.
    Steiner JA; Quansah E; Brundin P
    Cell Tissue Res; 2018 Jul; 373(1):161-173. PubMed ID: 29480459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?
    Breen DP; Halliday GM; Lang AE
    Mov Disord; 2019 Mar; 34(3):307-316. PubMed ID: 30653258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses.
    Jan A; Gonçalves NP; Vaegter CB; Jensen PH; Ferreira N
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
    Sharma N; Nehru B
    Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
    Brás IC; Outeiro TF
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein in Parkinson's Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role?
    Zheng H; Shi C; Luo H; Fan L; Yang Z; Hu X; Zhang Z; Zhang S; Hu Z; Fan Y; Yang J; Mao C; Xu Y
    Neuroscientist; 2021 Aug; 27(4):367-387. PubMed ID: 32729773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion-like propagation of pathology in Parkinson disease.
    Volpicelli-Daley L; Brundin P
    Handb Clin Neurol; 2018; 153():321-335. PubMed ID: 29887143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.